Exelixis
EXEL
#1855
Rank
HK$86.98 B
Marketcap
HK$323.13
Share price
-2.18%
Change (1 day)
25.94%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2025 (TTM): HK$6.80 Billion

According to Exelixis's latest financial reports the company's current earnings are HK$2.28 Billion. In 2024 the company made an earning of HK$5.32 Billion, an increase over its 2023 earnings that were of HK$2.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$6.80 B27.83%
2024 HK$5.32 B164.69%
2023 HK$2.01 B9.89%
2022 HK$1.83 B-20.33%
2021 HK$2.29 B124.82%
2020 HK$1.02 B-67.14%
2019 HK$3.11 B-11.94%
2018 HK$3.53 B185.09%
2017 HK$1.23 B-325.82%
2016 -HK$0.55 Billion-58.12%
2015 -HK$1.31 Billion-37.61%
2014 -HK$2.1 Billion9.75%
2013 -HK$1.92 Billion65.96%
2012 -HK$1.16 Billion-291.63%
2011 HK$0.60 B-195.59%
2010 -HK$0.63 Billion-42.17%
2009 -HK$1.09 Billion-18.98%
2008 -HK$1.35 Billion-6.99%
2007 -HK$1.45 Billion46.3%
2006 -HK$0.99 Billion33.25%
2005 -HK$0.75 Billion-30.92%
2004 -HK$1.08 Billion44.29%
2003 -HK$0.75 Billion12.86%
2002 -HK$0.66 Billion22.79%
2001 -HK$0.54 Billion60.14%
2000 -HK$0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$253.10 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$92.59 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$64.40 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$71.09 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$180.39 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.75 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$72.83 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-HK$0.26 Billion-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$0.23 Billion-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA